CJC-1295 (no DAC) + Hexarelin

CJC-1295 (no DAC) + Hexarelin is a specialized peptide blend combining the growth hormone-releasing peptide Hexarelin and the modified growth hormone-releasing factor CJC-1295 (without DAC). This combination acts by stimulating the pituitary gland to increase the production and release of growth hormone. CJC-1295 (no DAC) + Hexarelin first drew attention for its potential to enhance growth hormone secretion, sparking interest in its effects on body composition and recovery processes. Researchers have been particularly intrigued by its dual-action mechanism, which leverages both peptides to potentially amplify growth hormone release more effectively than either could alone. Today, it is primarily studied for its effects on:

• Growth hormone secretion studies
• Body composition research
• Recovery and rehabilitation processes

Secondary research interest includes the exploration of its effects on metabolic pathways.

PeptideSource editorial · Updated Jul 19, 2026